Abstract:BackgroundIn the classical pathway of retinoic acid (RA) mediated gene transcription, RA binds to a nuclear hormone receptor dimer composed of retinoic acid receptor (RAR) and retinoid X receptor (RXR), to induce the expression of its downstream target genes. In addition to nuclear receptors, there are other intracellular RA binding proteins such as cellular retinoic acid binding proteins (CRABP1 and CRABP2) and cytochrome P450 (CYP) enzymes, whose contributions to the RA signaling pathway have not been fully understood. The objective of this study was to compare the significance of various RA binding receptors, i.e. CRABP1, CRABP2, CYP and RAR in the RA signaling pathway. In this regard, we developed a mathematical model of the RA pathway, which is one of the few models, if not the only one, that includes all main intracellular RA binding receptors. We then performed a global sensitivity analysis (GSA) to investigate the contribution of the RA receptors to RA-induced mRNA production, when the cells were treated with a wide range of RA levels, from physiological to pharmacological concentrations.ResultsOur results show that CRABP2 and RAR are the most and the least important proteins, respectively, in controlling the model performance at physiological concentrations of RA (1–10 nM). However, at higher concentrations of RA, CYP and RAR are the most sensitive parameters of the system. Furthermore, we found that depending on the concentrations of all RA binding proteins, the rate of metabolism of RA can either change or remain constant following RA therapy. The cellular levels of CRABP1 are more important than that of CRABP2 in controlling RA metabolite formation at pharmacological conditions (RA = 0.1–1 μM). Finally, our results indicate a significant negative correlation between total mRNA production and total RA metabolite formation at pharmacological levels of RA.ConclusionsOur simulations indicate that the significance of the RA binding proteins in the RA pathway of gene expression strongly depends on intracellular concentration of RA. This study not only can explain why various cell types respond to RA therapy differently, but also can potentially help develop pharmacological methods to increase the efficacy of the drug.

A decade of molecular biology of retinoic acid receptors

The Pathophysiological Roles and Regulatory Mechanism of Retinoic Acid Receptor-related Orphan Receptors

Molecular Recognition of CYP26A1 Binding Pockets and Structure–activity Relationship Studies for Design of Potent and Selective Retinoic Acid Metabolism Blocking Agents

Structural Basis for Retinoic X Receptor Repression on the Tetramer

Retinoic acid signaling in development and differentiation commitment and its regulatory topology

Post-translational Modification of Retinoic Acid Receptor Alpha and Its Roles in Tumor Cell Differentiation

Molecular Interactions of Selective Agonists and Antagonists with the Retinoic Acid Receptor γ

Towards a Better Vision of Retinoic Acid Signaling during Eye Development

Retinoid-dependent in vitro transcription mediated by the RXR/RAR heterodimer.

The retinoid X receptor has a critical role in synthetic rexinoid-induced increase in cellular all- trans -retinoic acid

Comparison of phenotypic and global gene expression changes in Xenopus tropicalis embryos induced by agonists of RAR and RXR.

THE SYNTHESIS AND PRELIMINARY EVALUATION OF SUBSTITUTED CHROMONES, COUMARINS, CHROMANONES, AND BENZOPHENONES AS RETINOIC ACID RECEPTOR LIGANDS

Identification of influential proteins in the classical retinoic acid signaling pathway

Retinoic Acid Nuclear Receptor Α (rarα), a Major Role in Mediating Retinoids Inhibition of Growth in Human Breast Carcinoma Cells

Retinoid Synthesis Regulation by Retinal Cells in Health and Disease

Targeting Expression of a Dominant-Negative Retinoic Acid Receptor Mutant in the Epidermis of Transgenic Mice Results in Loss of Barrier Function.

Retinoic acid receptor regulation of decision-making for cell differentiation

Structure–Activity Relationships and Therapeutic Applications of Retinoids in View of Potential Benefits from Drug Repurposing Process

A review of the molecular design and biological activities of RXR agonists

Loss of CAK phosphorylation of RAR{alpha} mediates transcriptional control of retinoid-induced cancer cell differentiation.

Impact of Retinoic Acid on Immune Cells and Inflammatory Diseases